Caribou Biosciences, Inc. (CRBU) Tops Q3 EPS by 4c

Caribou Biosciences, Inc. (NASDAQ: CRBU) reported Q3 EPS of ($0.44), $0.04 better than the analyst estimate of ($0.48). Revenue for the quarter came in at $3.3 million versus the consensus estimate of $3.54 million.

For earnings history and earnings-related data on Caribou Biosciences, Inc. (CRBU) click here.

You May Also Be Interested In

• Micron offers Taiwan workers up to 68-month bonuses as strike threat looms
• S&P 500 above 8,000 in 2026 now looks ambitious, Citi says
• Hooker Furniture (HOFT) Tops Q2 EPS by 16c, Misses on Revenue